je.st

Home › responses

Tag: responses

Emulate's Lung-Chip Demonstrates New Capabilities To Predict Human Lung Inflammation And Drug Responses In Asthma And COPD

2016-01-06 06:32:00| drugdiscoveryonline Home Page

Emulate Inc. announced recently that it has developed a new living human Lung-Chip system that accurately recreates the unique structure and function of the human lung small airways within microengineered chips - as reported today in the journal Nature Methods

Tags: human drug responses capabilities

Responses Observed in Three-Quarters of Heavily Pre-Treated Multiple Myeloma Patients Receiving KEYTRUDA (pembrolizumab) Combined With Lenalidomide and Dexamethasone

2015-12-07 13:00:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. Findings Presented at the 57th American Society of Hematology Annual Meeting Demonstrate Activity of KEYTRUDA Therapy in Previously-Treated Multiple Myeloma Patients When Combined with Lenalidomide and Dexamethasone KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today new study findings investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in combination with lenalidomide and low-dose dexamethasone (two commonly used treatments for multiple myeloma) in patients whose disease has progressed after at least two lines of prior therapy, including a proteasome inhibitor and an IMiD (immune modulatory drug). Language: English Contact: Media:Pamela Eisele, 267-305-3558orKim Hamilton, 908-391-0131orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: multiple combined observed receiving